Eye on H1N1

Sunday, 1 Nov 2009 | 7:24 PM ET

Manufacturers are having issues with yields from strains used to produce H1N1 vaccines, says Rhenu Bhuller, global VP of pharmaceuticals at Frost & Sullivan. She sheds light on what is happening, with guest host, Greg Bundy of AIMS Finance & CNBC's Martin Soong.